Literature DB >> 7740561

Anticardiolipin antibodies in normal subjects. Neuropsychological correlates and MRI findings.

R Schmidt1, P Auer-Grumbach, F Fazekas, H Offenbacher, P Kapeller.   

Abstract

BACKGROUND AND
PURPOSE: Our aim was to assess the association of elevated anticardiolipin antibody (aCL) titers with silent brain damage and cognitive functioning in middle-aged and elderly normal subjects.
METHODS: We determined the IgM and IgG aCL titers from 233 randomly selected clinically normal participants of a population-based stroke prevention study (age range, 44 to 82 years). aCL titers were categorized into negative (0 to 10 U/L), low positive (10 to 20 U/L), and moderately high positive (> 20 U/L). All participants underwent 1.5-T MRI and demanding neuropsychological testing. Semiautomated measurements of the total white matter hyperintensity area and the size of ventricles and cortical sulci were conducted.
RESULTS: There were 180 subjects (77.3%) with negative, 35 (15.0%) with low positive, and 18 (7.7%) with moderately high positive aCL titers. The frequency and extent of focal and diffuse brain abnormalities were not related to the aCL status of those examined. However, subjects with positive aCL results performed worse than those with negative findings on almost all tests administered, and this effect was mainly IgG titer related. When an ANCOVA test and partial correlations to correct for slight group differences in age and for the presence of major vascular risk factors were used, values of P < .05 were noted on tests assessing mnemonic and visuopractical abilities.
CONCLUSION: Increased aCL titers in normal elderly persons may be associated with subtle neuropsychological dysfunction, but they do not appear to cause any morphological changes as demonstrated by MRI.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7740561     DOI: 10.1161/01.str.26.5.749

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  11 in total

Review 1.  Antiphospholipid antibodies in young adults with stroke.

Authors:  Robin L Brey
Journal:  J Thromb Thrombolysis       Date:  2005-10       Impact factor: 2.300

2.  Anticardiolipin antibodies in the sera of patients with diagnosed chronic fatigue syndrome.

Authors:  Yoshitsugi Hokama; Cara Empey Campora; Cynthia Hara; Tina Kuribayashi; Diana Le Huynh; Kenichi Yabusaki
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

Review 3.  Neurologic manifestations of the antiphospholipid syndrome.

Authors:  D Tanne; S Hassin-Baer
Journal:  Curr Rheumatol Rep       Date:  2001-08       Impact factor: 4.592

Review 4.  Cognitive dysfunction and antiphospholipid antibodies.

Authors:  Simone Appenzeller; Aline Tamires Lapa; Jozélio Freire de Carvalho; Fernando Augusto Peres; Yehuda Shoenfeld
Journal:  Curr Rheumatol Rep       Date:  2012-02       Impact factor: 4.592

5.  Antiphospholipid Antibodies: Cognitive and Motor Decline, Neuroimaging and Neuropathology.

Authors:  Zoe Arvanitakis; Ana W Capuano; Robin Brey; Debra A Fleischman; Konstantinos Arfanakis; Aron S Buchman; Julie A Schneider; Steven R Levine; David A Bennett
Journal:  Neuroepidemiology       Date:  2019-05-08       Impact factor: 3.282

6.  MRI characteristics of patients with antiphospholipid syndrome and multiple sclerosis.

Authors:  Milena Stosic; Julian Ambrus; Neeta Garg; Bianca Weinstock-Guttman; Murali Ramanathan; Bernadette Kalman; Alireza Minagar; Frederick E Munschauer; Timothy M Galey; Sara Hussein; Rohit Bakshi; Robert Zivadinov
Journal:  J Neurol       Date:  2009-07-26       Impact factor: 4.849

Review 7.  Neurologic manifestations of the antiphospholipid syndrome.

Authors:  Jose F Roldan; Robin L Brey
Journal:  Curr Rheumatol Rep       Date:  2007-05       Impact factor: 4.592

8.  Neurocognitive dysfunction in systemic lupus erythematosus: association with antiphospholipid antibodies, disease activity and chronic damage.

Authors:  Fabrizio Conti; Cristiano Alessandri; Carlo Perricone; Rossana Scrivo; Soheila Rezai; Fulvia Ceccarelli; Francesca Romana Spinelli; Elena Ortona; Massimo Marianetti; Concetta Mina; Guido Valesini
Journal:  PLoS One       Date:  2012-03-26       Impact factor: 3.240

9.  Chorea associated with high titers of antiphospholipid antibodies in the absence of antiphospholipid antibody syndrome.

Authors:  Damoun Safarpour; Sarah Buckingham; Bahman Jabbari
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2015-02-13

10.  Presence of Anticardiolipin Antibodies in Patients with Dementia: A Systematic Review and Meta-Analysis.

Authors:  Md Asiful Islam; Fahmida Alam; Mohammad Amjad Kamal; Siew Hua Gan; Teguh Haryo Sasongko; Kah Keng Wong
Journal:  Front Aging Neurosci       Date:  2017-08-02       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.